← Open Payments lookup

JAMIE THOMAS: Open Payments

NPI 1801409966 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,453 in 147 payments from 18 companies in 2025. Trend: 2023 $1,790 · 2024 $1,625 · 2025 $3,453

Food & beverage: $3,435Education: $18
CompanyPaymentsAmount
Janssen Biotech, Inc.39$867
Madrigal Pharmaceuticals11$402
ABBVIE INC.23$388
Takeda Pharmaceuticals U.S.A., Inc.17$318
Regeneron Healthcare Solutions, Inc.5$252
Ipsen Biopharmaceuticals, Inc8$227
Phathom Pharmaceuticals, Inc.8$215
QOL Medical, LLC7$161
Ardelyx, Inc.5$128
Gilead Sciences, Inc.5$93

Products named: TREMFYA, REZDIFFRA, DUPIXENT, VOQUEZNA, ENTYVIO, Sucraid, IQIRVO, RINVOQ.

Industry payments across NY — which companies pay providers there.